The assessment of cardiac hypertrophy at autopsy

Histopathology
|December 1, 1985
PubMed

Insights

Body size predicts normal adult human heart and ventricle weights, with body weight being a superior predictor over height. The Fulton technique is reliable for assessing ventricular hypertrophy, but arbitrary limits may cause errors.

Area of Science:

  • Cardiovascular Physiology
  • Human Anatomy

Background:

  • Heart and ventricular weights correlate with body size in adults.
  • Assessing ventricular hypertrophy using wall thickness is unreliable.
  • Existing methods for determining ventricular hypertrophy have limitations.

Purpose of the Study:

  • To evaluate the relationship between body size and heart/ventricular weights.
  • To assess the efficacy of different predictors for heart and ventricular mass.
  • To determine the most reliable method for diagnosing ventricular hypertrophy.

Main Methods:

  • Correlation analysis between body size parameters (weight, height) and heart/ventricular weights.
  • Evaluation of ventricular wall thickness as an indicator of hypertrophy.
  • Application of the Fulton technique for isolated ventricular weight determination.

Main Results:

  • Total heart weight and individual ventricular weights are proportional to body size.
  • Body weight is a more accurate predictor of heart and ventricular weights than height.
  • Ventricular wall thickness is an insensitive measure for hypertrophy.
  • Heart weight is a poor predictor for right ventricular mass but better for left.
  • The Fulton technique is the most reliable method for assessing isolated ventricular weights.

Conclusions:

  • Body size, particularly body weight, is a key determinant of normal adult human heart and ventricular mass.
  • While the Fulton technique is the gold standard for hypertrophy assessment, arbitrary limits in its application can lead to diagnostic inaccuracies.
  • Further refinement of interpretation criteria for the Fulton technique is warranted to improve diagnostic accuracy for ventricular hypertrophy.

Related Concept Videos

Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...